Follow
Devin Incerti
Devin Incerti
EntityRisk, Inc.
Verified email at entityrisk.com - Homepage
Title
Cited by
Cited by
Year
Short-term costs of preeclampsia to the United States health care system
W Stevens, T Shih, D Incerti, TGN Ton, HC Lee, D Peneva, GA Macones, ...
American journal of obstetrics and gynecology 217 (3), 237-248. e16, 2017
2952017
R you still using excel? The advantages of modern software tools for health technology assessment
D Incerti, H Thom, G Baio, JP Jansen
Value in Health 22 (5), 575-579, 2019
452019
Assessing variation in the cost of palivizumab for respiratory syncytial virus prevention in preterm infants
A Shahabi, D Peneva, D Incerti, K McLaurin, W Stevens
PharmacoEconomics-open 2, 53-61, 2018
452018
Prognostic model to identify and quantify risk factors for mortality among hospitalised patients with COVID-19 in the USA
D Incerti, S Rizzo, X Li, L Lindsay, V Yau, D Keebler, J Chia, L Tsai
BMJ open 11 (4), e047121, 2021
37*2021
Cost-effectiveness of genome sequencing for diagnosing patients with undiagnosed rare genetic diseases
D Incerti, XM Xu, JW Chou, N Gonzaludo, JW Belmont, BE Schroeder
Genetics in Medicine 24 (1), 109-118, 2022
302022
Maternal and infant adverse outcomes associated with mild and severe preeclampsia during the first year after delivery in the United States
TGN Ton, MV Bennett, D Incerti, D Peneva, M Druzin, W Stevens, ...
American journal of perinatology 37 (04), 398-408, 2020
282020
Penalized regression for left‐truncated and right‐censored survival data
SF McGough, D Incerti, S Lyalina, R Copping, B Narasimhan, R Tibshirani
Statistics in Medicine 40 (25), 5487-5500, 2021
272021
hesim: Health economic simulation modeling and decision analysis
D Incerti, JP Jansen
arXiv preprint arXiv:2102.09437, 2021
25*2021
A flexible open-source decision model for value assessment of biologic treatment for rheumatoid arthritis
D Incerti, JR Curtis, J Shafrin, DN Lakdawalla, JP Jansen
Pharmacoeconomics 37, 829-843, 2019
252019
Incremental net monetary benefit of ocrelizumab relative to subcutaneous interferon β-1a
MA Frasco, T Shih, D Incerti, O Diaz Espinosa, DK Vania, N Thomas
Journal of medical economics 20 (10), 1074-1082, 2017
252017
Cost-effectiveness of sequenced treatment of rheumatoid arthritis with targeted immune modulators
JP Jansen, D Incerti, A Mutebi, D Peneva, JP MacEwan, B Stolshek, ...
Journal of Medical Economics 20 (7), 703-714, 2017
252017
The economic burden of kidney graft failure in the United States
J Sussell, AR Silverstein, P Goutam, D Incerti, R Kee, CX Chen, ...
American Journal of Transplantation 20 (5), 1323-1333, 2020
232020
The lifetime health burden of delayed graft function in kidney transplant recipients in the United States
D Incerti, N Summers, TGN Ton, A Boscoe, A Chandraker, W Stevens
MDM Policy & Practice 3 (1), 2381468318781811, 2018
222018
Developing open-source models for the US health system: practical experiences and challenges to date with the open-source value project
JP Jansen, D Incerti, MT Linthicum
Pharmacoeconomics 37 (11), 1313-1320, 2019
172019
Opportunities and barriers to the development and use of open source health economic models: a survey
XGLV Pouwels, CJ Sampson, RJG Arnold, MD Janodia, R Henderson, ...
Value in health 25 (4), 473-479, 2022
122022
Left truncation in linked data: A practical guide to understanding left truncation and applying it using SAS and R
Y Jin, TGN Ton, D Incerti, S Hu
Pharmaceutical Statistics 22 (1), 194-204, 2023
72023
The optimal allocation of campaign funds in US House elections
D Incerti
Electoral Studies 56, 102-113, 2018
62018
Toward relevant and credible cost-effectiveness analyses for value assessment in the decentralized US health care system
JP Jansen, D Incerti, JR Curtis
Journal of Managed Care & Specialty Pharmacy 25 (5), 518-521, 2019
52019
An open-source consensus-based approach to value assessment
JP Jansen, D Incerti, MT Linthicum
Health Affairs Forefront, 2017
52017
Are regime changes always bad economics? Evidence from daily financial data
D Incerti, T Incerti
Business and Politics, 1-24, 2021
4*2021
The system can't perform the operation now. Try again later.
Articles 1–20